NCT03108950 (TExT-ME) is a NA clinical trial of Movement to Music in Multiple Sclerosis, sponsored by University of Alabama at Birmingham.

Who is sponsoring NCT03108950?

NCT03108950 is sponsored by University of Alabama at Birmingham.

What drugs are being tested in NCT03108950?

Interventions in NCT03108950: Movement to Music.

What condition does NCT03108950 study?

NCT03108950 studies Multiple Sclerosis, Stroke.

Is NCT03108950 still recruiting?

NCT03108950 is currently completed. Last updated 5 August 2019.

Last reviewed 2019-08-05 · How we verify

NCT03108950: TExT-ME

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

From Clinic to Community: An Information and Communication Technology (ICT) Home-Based Exercise Training System for Translating Clinical Findings

Completed NA Last updated 5 August 2019

What this trial tests

NA trial testing Movement to Music in Multiple Sclerosis in 27 participants. Completed in 31 May 2019.

Timeline

1 February 2017

Primary endpoint
31 May 2019

31 May 2019

Quick facts

Lead sponsor	University of Alabama at Birmingham
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	27
Start date	1 February 2017
Primary completion	31 May 2019
Estimated completion	31 May 2019
Sites	1 location across United States

Drugs / interventions tested

Movement to Music

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →
Stroke — all drugs for Stroke →

Sponsor

University of Alabama at Birmingham

Who can join

Adults 18 to 65, any sex, with Multiple Sclerosis or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The specific aim of the study in our example is to conduct a feasibility translational home-based exercise trial established in the LEADERS (R2) project with the TExt-ME tele-exercise training system for participants with neurologic disability. We hypothesize that participants in this home-based tele-exercise training program will achieve similar gains in health and function outcomes as the onsite exercise training program. Further, there will be no difference in adverse side effects (safety) between the home-based and onsite exercise treatment groups.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Methodological and clinical implications of a three-in-one Russian doll design for tracking health trajectories and improving health and function through innovative exercise treatments in adults with disability.
Rimmer JH, Herman C, Wingo B, Fontaine K, et al · · 2018 · PMID 29540164 · DOI 10.1186/s12874-018-0480-3

Verify or expand the search:

Other trials of Movement to Music

Trials testing the same drug.

NCT05270681 — Move to Improve: Telehealth Exercise to Music for HD · NA · completed

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03108950 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
Last refreshed: 5 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03108950.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing